567
Participants
Start Date
December 6, 2017
Primary Completion Date
January 8, 2019
Study Completion Date
December 13, 2019
Bimekizumab
Bimekizumab will be provided at pre-specified time intervals.
Ustekinumab
Ustekinumab will be provided as dose 1 for subjects weighing \<=100 kg and as dose 2 for subjects weighing \>100 kg at pre-specified time intervals.
Placebo
Subjects will receive Placebo at pre-specified time points.
Ps0009 941, Alpharetta
Ps0009 921, Ormond Beach
Ps0009 912, Coral Gables
Ps0009 907, Miami
Ps0009 909, Boynton Beach
Ps0009 906, Boca Raton
Ps0009 918, Tampa
Ps0009 903, Ocala
Ps0009 911, Plainfield
Ps0009 917, Troy
Ps0009 900, West Des Moines
Ps0009 915, St Louis
Ps0009 905, Overland Park
Ps0009 958, Omaha
Ps0009 922, Baton Rouge
Ps0009 924, Houston
Ps0009 914, San Antonio
Ps0009 946, Phoenix
Ps0009 923, Albuquerque
Ps0009 919, San Diego
Ps0009 910, Bakersfield
Ps0009 920, Portland
Ps0009 901, Portsmouth
Ps0009 908, East Windsor
Ps0009 913, New York
Ps0009 004, Fremantle
Ps0009 005, Phillip
Ps0009 002, Westmead
Ps0009 009, Woolloongabba
Ps0009 050, Brussels
Ps0009 052, Liège
Ps0009 051, Loverval
Ps0009 673, Halifax
Ps0009 652, Oakville
Ps0009 651, Richmond Hill
Ps0009 650, Surrey
Ps0009 653, Toronto
Ps0009 657, Waterloo
Ps0009 218, Bonn
Ps0009 209, Darmstadt
Ps0009 214, Erlangen
Ps0009 208, Frankfurt am Main
Ps0009 210, Friedrichshafen
Ps0009 211, Hamburg
Ps0009 212, Heidelberg
Ps0009 213, Mahlow
Ps0009 205, Osnabrück
Ps0009 217, Schweinfurt
Ps0009 254, Budapest
Ps0009 255, Budapest
Ps0009 253, Orosháza
Ps0009 259, Szekszárd
Ps0009 300, Roma
Ps0009 303, Roma
Ps0009 629, Asahikawa
Ps0009 605, Bunkyō City
Ps0009 607, Chiyoda City
Ps0009 610, Chūōku
Ps0009 601, Fukuoka
Ps0009 619, Gifu
Ps0009 620, Hamamatsu
Ps0009 608, Itabashi-Ku
Ps0009 627, Itabashi-Ku
Ps0009 609, Kobe
Ps0009 600, Kurume
Ps0009 622, Matsumoto
Ps0009 604, Minatoku
Ps0009 623, Morioka
Ps0009 621, Nagoya
Ps0009 625, Nankoku
Ps0009 624, Obihiro
Ps0009 611, Osaka
Ps0009 614, Osaka
Ps0009 603, Sapporo
Ps0009 617, Sendai
Ps0009 613, Shimotsuke
Ps0009 602, Shinagawa-Ku
Ps0009 612, Shinjuku-Ku
Ps0009 618, Shinjuku-Ku
Ps0009 626, Shinjuku-Ku
Ps0009 628, Shinjuku-Ku
Ps0009 615, Sumida City
Ps0009 606, Takaoka
Ps0009 616, Tsu
Ps0009 362, Bialystok
Ps0009 369, Bialystok
Ps0009 371, Bydgoszcz
Ps0009 358, Katowice
Ps0009 357, Kielce
Ps0009 372, Lodz
Ps0009 374, Poznan
Ps0009 350, Warsaw
Ps0009 351, Warsaw
Ps0009 367, Wroclaw
Ps0009 370, Wroclaw
Ps0009 400, Moscow
Ps0009 402, Moscow
Ps0009 403, Moscow
Ps0009 404, Saint Petersburg
Ps0009 556, Cardiff
Ps0009 551, Dundee
Ps0009 553, Edgbaston
Ps0009 552, Liverpool
Ps0009 550, Manchester
Ps0009 555, Salford
UCB Biopharma SRL
INDUSTRY